| |
 |
SYM |
Description |
 |
|
4118 |
Supplier of key intermediates used for ACE-inhibitors. |
 |
|
|
|
|
|
|
|
MGRM |
Formerly ViroLogic, Mongram develops, markets and sells products to guide and improve treatment of viral diseases.
|
|
|
|
|
|
|
|
|
CRA |
Molecular diagnostics for infectious disease testing and genetic conditions such as cystic fibrosis. |
|
|
|
|
|
|
|
|
PGNT |
Currently seeking new business opportunities. |
|
|
|
|
|
|
|
|
ADVR |
Drug development |
|
|
|
|
|
|
|
|
Private |
Rapid tests for infectious diseases. |
|
|
|
|
|
|
|
|
Private |
Medical ozone. |
|
|
|
|
|
|
|
|
Private |
Immunoassay kits and instruments. |
|
|
|
|
|
|
|
|
HEB |
Dug development for treatment of viral and immune based chronic disorders. |
|
|
|
|
|
|
|
|
Private |
Development of bio-processes, vaccines and biopharmaceuticals for human application. |
|
|
|
|
|
|
|
|
Private |
Molecular diagnostic tests that have high, individualized predictive value. |
|
|
|
|
|
|
|
|
Private |
HIV diagnostics and treatments. |
|
|
|
|
|
|
|
|
Private |
Viral diseases monitoring and diagnostics. |
|
|
|
|
|
|
|
|
Private |
Enzymes for the diagnostic healthcare market. |
|
|
|
|
|
|
|
Efoora |
|
Elk Grove Village,, IL |
USA |
|
Private |
Rapid diagnosis test. |
|
|
|
|
|
|
|
|
Private |
Healthcare-related diagnostics. |
|
|
|
|
|
|
|
|
NGNM |
Testing in clinical genetics, molecular diagnostics, and flow cytometry. |
|
|
|
|
|
|
|
|
Private |
Dietary supplements and generic versions of non-prescription pharmaceuticals. |
|
|
|
|
|
|
|
|
TH |
Technology company engaged in the discovery and development of therapeutic products in the fields of endocrinology and metabolism. |
|
|
|
|
|
|
|
|
LIPD |
Treat medical conditions in which lipids or fat components play a key role. |
|
|
|
|
|
|
|
|
private |
AusAm is developing new methods to identify and treat major diseases. |
|
|
|
|
|
|
|
|
Private |
MicroSERS for drug discovery and development, and bioscience research. |
|
|
|
|
|
|
|
|
WDH |
Speech intelligibility solution for those with hearing loss. |
|
|
|
|
|
|
|
MedMira |
|
Halifax, Nova Scotia |
Canada |
|
MIR |
Rapid diagnostic tests for infectious diseases. |
|
|
|
|
|
|
|
|
VRUS |
Therapeutics for infections caused by human immunodeficiency virus and hepatitis viruses. |
|
|
|
|
|
|
|
|
BBII |
Products and services to diagnostics, life sciences and pharmaceutical industries |
|
|
|
|
|
|
|
|
IDEV |
The Company has a broad portfolio of drugs in development. |
|
|
|
|
|
|
|
|
MYMX |
Mymetics is a biotechnology company developing vaccines and therapies to treat AIDS. |
|
|
|
|
|
|
|
|
Private |
Selective Viral Mutagenesis technology development for drugs to treat HIV and HCV. |
|
|
|
|
|
|
|
Virco |
|
Mechelen, BEL |
Belgium |
|
Private |
Diagnostic services for the management of HIV infection. |
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
OneMedPlace Member
